Literature DB >> 23518455

Caenorhabditis elegans: modest increase of susceptibility to ivermectin in individual P-glycoprotein loss-of-function strains.

I Jana I Janssen1, Jürgen Krücken, Janina Demeler, Georg von Samson-Himmelstjerna.   

Abstract

P-glycoproteins (Pgps) are members of the ABC transporter superfamily and are involved in detoxification mechanisms of single- and multicellular organisms. Their importance for survival of organisms in the presence of harmful drug concentrations has been widely studied in cancer cells but Pgp-dependent drug resistance of parasites has also been demonstrated. Ivermectin (IVM), a widely used anthelmintic in human and veterinary medicine, is a known substrate at least of mammalian Pgps and resistance against IVM is proposed to be associated with Pgps. The consequences of loss of Pgp function for the development of the model nematode Caenorhabditis elegans were analysed in the presence of IVM. Either strains missing only a single Pgp were used or Pgp activity generally was inhibited using verapamil (VPL). Loss-of-function of individual Pgp resulted in a statistically significant increase in IVM susceptibility in terms of impaired development with decreases in EC₅₀ values between 1.5- and 4.3-fold. Absence of seven Pgps resulted in a higher impact on IVM susceptibility of C. elegans since it resulted in EC₅₀ values decreased by 2.4- to 4.3-fold. This increase in IVM susceptibility was even more pronounced than that observed when Pgp function was blocked in general by VPL (approximately 2.5-fold). This study demonstrates clearly that Pgps are of importance for IVM detoxification in the model organism C. elegans and that some Pgps obviously have a higher impact than others.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23518455     DOI: 10.1016/j.exppara.2013.03.005

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  16 in total

1.  Acquired Tolerance to Ivermectin and Moxidectin after Drug Selection Pressure in the Nematode Caenorhabditis elegans.

Authors:  Cécile Ménez; Mélanie Alberich; Dalia Kansoh; Alexandra Blanchard; Anne Lespine
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

2.  Transgenically expressed Parascaris P-glycoprotein-11 can modulate ivermectin susceptibility in Caenorhabditis elegans.

Authors:  I Jana I Janssen; Jürgen Krücken; Janina Demeler; Georg von Samson-Himmelstjerna
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2015-04-08       Impact factor: 4.077

3.  Macrocyclic lactones differ in interaction with recombinant P-glycoprotein 9 of the parasitic nematode Cylicocylus elongatus and ketoconazole in a yeast growth assay.

Authors:  Maximiliane Kaschny; Janina Demeler; I Jana I Janssen; Tetiana A Kuzmina; Bruno Besognet; Theo Kanellos; Dominique Kerboeuf; Georg von Samson-Himmelstjerna; Jürgen Krücken
Journal:  PLoS Pathog       Date:  2015-04-07       Impact factor: 6.823

Review 4.  Recent advances in candidate-gene and whole-genome approaches to the discovery of anthelmintic resistance markers and the description of drug/receptor interactions.

Authors:  Andrew C Kotze; Peter W Hunt; Philip Skuce; Georg von Samson-Himmelstjerna; Richard J Martin; Heinz Sager; Jürgen Krücken; Jane Hodgkinson; Anne Lespine; Aaron R Jex; John S Gilleard; Robin N Beech; Adrian J Wolstenholme; Janina Demeler; Alan P Robertson; Claude L Charvet; Cedric Neveu; Ronald Kaminsky; Lucien Rufener; Melanie Alberich; Cecile Menez; Roger K Prichard
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-08-13       Impact factor: 4.077

5.  Resistance to the macrocyclic lactone moxidectin is mediated in part by membrane transporter P-glycoproteins: Implications for control of drug resistant parasitic nematodes.

Authors:  Elizabeth E Bygarski; Roger K Prichard; Bernadette F Ardelli
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-07-12       Impact factor: 4.077

6.  ABC-B transporter genes in Dirofilaria immitis.

Authors:  Catherine Bourguinat; Hua Che; Thangadurai Mani; Kathy Keller; Roger K Prichard
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2016-04-08       Impact factor: 4.077

7.  In silico analysis of the binding of anthelmintics to Caenorhabditis elegansP-glycoprotein 1.

Authors:  Marion A David; Stéphane Orlowski; Roger K Prichard; Shaima Hashem; François André; Anne Lespine
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2016-09-15       Impact factor: 4.077

8.  P-glycoproteins play a role in ivermectin resistance in cyathostomins.

Authors:  L E Peachey; G L Pinchbeck; J B Matthews; F A Burden; A Lespine; G von Samson-Himmelstjerna; J Krücken; J E Hodgkinson
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-10-25       Impact factor: 4.077

9.  Polymorphism in ABC transporter genes of Dirofilaria immitis.

Authors:  Thangadurai Mani; Catherine Bourguinat; Roger K Prichard
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-04-29       Impact factor: 4.077

10.  Dominance of P-glycoprotein 12 in phenotypic resistance conversion against ivermectin in Caenorhabditis elegans.

Authors:  Luiza Almeida Figueiredo; Thais Fuscaldi Rebouças; Sebastião Rodrigo Ferreira; Gabriela Flavia Rodrigues-Luiz; Rodrigo Cambraia Miranda; Ricardo Nascimento Araujo; Ricardo Toshio Fujiwara
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.